Literature DB >> 2787381

Activation of natural killer cells via the p75 interleukin 2 receptor.

J H Phillips1, T Takeshita, K Sugamura, L L Lanier.   

Abstract

The IL-2R is composed of at least two subunits, the p55 (CD25/Tac) and p75 glycoproteins. The p75 IL-2R is expressed preferentially on resting human peripheral blood NK cells, but is not detected on substantial proportions of T and B lymphocytes, monocytes, or granulocytes. Anti-p75 IL-2R mAb substantially inhibits the early events associated with NK cell activation by IL-2, including inhibition of cytotoxic activity and induction of the CD69 early activation antigen. While anti-p55 IL-2R mAb alone failed to substantially inhibit the initial events of IL-2 stimulation, maximal inhibition of IL-2-induced cytotoxicity and proliferation was achieved by combining both anti-p55 IL-2R and anti-p75 IL-2R. Collectively, results from the present studies directly implicate the p75 IL-2R as the structure predominantly responsible for IL-2 activation of NK cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787381      PMCID: PMC2189366          DOI: 10.1084/jem.170.1.291

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide.

Authors:  J Szöllösi; S Damjanovich; C K Goldman; M J Fulwyler; A A Aszalos; G Goldstein; P Rao; M A Talle; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Possible association between IL-2 receptors and class I HLA molecules on T cells.

Authors:  M Sharon; J R Gnarra; M Baniyash; W J Leonard
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

Review 3.  The interleukin 2 receptor.

Authors:  K A Smith
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

4.  The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.

Authors:  M Tsudo; C K Goldman; K F Bongiovanni; W C Chan; E F Winton; M Yagita; E A Grimm; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex.

Authors:  M Tsudo; R W Kozak; C K Goldman; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

Authors:  L L Lanier; A M Le; J H Phillips; N L Warner; G F Babcock
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

7.  In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing combined recombinant interleukin-2 and LAK cell therapy.

Authors:  J H Phillips; B T Gemlo; W W Myers; A A Rayner; L L Lanier
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

8.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Authors:  T Takeshita; Y Goto; K Tada; K Nagata; H Asao; K Sugamura
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

9.  Response of resting human peripheral blood natural killer cells to interleukin 2.

Authors:  G Trinchieri; M Matsumoto-Kobayashi; S C Clark; J Seehra; L London; B Perussia
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.

Authors:  L L Lanier; D W Buck; L Rhodes; A Ding; E Evans; C Barney; J H Phillips
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  37 in total

1.  Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.

Authors:  C Cambiaggi; M T Scupoli; T Cestari; F Gerosa; G Carra; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Activation of peripheral blood T cells via the p75 interleukin 2 receptor.

Authors:  H Yagita; M Nakata; A Azuma; T Nitta; T Takeshita; K Sugamura; K Okumura
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

3.  Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

Authors:  E Dagli; J A Warner; C R Besley; J O Warner
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

4.  Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1.

Authors:  K Eckert; E Grünberg; P Immenschuh; F Garbin; E D Kreuser; H R Maurer
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

5.  Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.

Authors:  L J Levitt; A Nagler; F Lee; J Abrams; M Shatsky; D Thompson
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.

Authors:  E A Grimm; J M Bruner; J Carinhas; J A Köppen; W G Loudon; L Owen-Schaub; P A Steck; R P Moser
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.

Authors:  A J Grant; E Roessler; G Ju; M Tsudo; K Sugamura; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.

Authors:  G Pang; A Buret; R T Batey; Q Y Chen; L Couch; A Cripps; R Clancy
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

9.  Relationship between IL-2 receptor expression and proliferative responses in lymphocytes from HIV-1 seropositive homosexual men.

Authors:  R K Chopra; N B Raj; J P Scally; A D Donnenberg; W H Adler; A J Saah; J B Margolick
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

10.  Study of IL-2 receptor expression after chemoimmunotherapy in patients treated for metastatic malignant melanoma.

Authors:  R Mouawad; M Ichen; O Rixe; A Benhammouda; E Vuillemin; M Weil; D Khayat; C Soubrane
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.